The Baldwin Insurance Group, Inc. (BWIN) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 4.34%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 4.34% | Share-based compensation / revenue. Period ending 2026-06-30. $74.88M ÷ $1.72B × 100 ≈ 4.34% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 1.72B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 74.88M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -119.63M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.72B | $74.88M | $-119.63M | (m) | (m) | 4.34% | (m) | (m) |
| 2026-03-31 | (m) | $1.61B | $71.13M | $-83.35M | (m) | (m) | 4.41% | (m) | (m) |
| 2025-12-31 | (m) | $1.49B | $71.11M | $73.94M | (m) | (m) | 4.76% | (m) | (m) |
| 2025-09-30 | (m) | $1.48B | $70.51M | $81.70M | (m) | (m) | 4.78% | (m) | (m) |
| 2025-06-30 | (m) | $1.45B | $66.44M | $93.89M | (m) | (m) | 4.59% | (m) | (m) |
| 2025-03-31 | (m) | $1.41B | $64.21M | $82.41M | (m) | (m) | 4.56% | (m) | (m) |
| 2024-12-31 | (m) | $1.38B | $65.50M | $60.65M | (m) | (m) | 4.76% | (m) | (m) |
| 2024-09-30 | (m) | $1.33B | $60.13M | $36.40M | (m) | (m) | 4.51% | (m) | (m) |
| 2024-06-30 | (m) | $1.30B | $56.78M | $21.08M | (m) | (m) | 4.36% | (m) | (m) |
| 2024-03-31 | (m) | $1.26B | $60.82M | $-11.91M | (m) | (m) | 4.83% | (m) | (m) |
| 2023-12-31 | (m) | $1.21B | $60.01M | $-42.55M | (m) | (m) | 4.95% | (m) | (m) |
| 2023-09-30 | (m) | (m) | $67.96M | $-79.25M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | $61.75M | $-109.19M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | $53.11M | $-67.22M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $47.39M | $-31.10M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | $33.34M | $-2.54M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | $28.78M | $10.14M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | $23.21M | $-28.84M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | $19.19M | $-31.63M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | $14.31M | $-7.51M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | $12.71M | $2.63M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | $10.15M | $9.02M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | $7.74M | $-21.94M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | $8.47M | $-26.72M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | $6.31M | $-18.57M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | $4.37M | $-11.10M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $3.23M | $-5.07M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | $14.10M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | $14.53M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | $1.24M | $9.53M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Goosehead Insurance, Inc. (GSHD) | United States | $0.922B | 276.12 |
| Roadzen Inc. (RDZN) | United States | $0.109B | |
| SelectQuote, Inc. (SLQT) | United States | $0.073B | 2.34 |
| eHealth, Inc. (EHTH) | United States | $0.026B | 1.75 |
| Reliance Global Group, Inc. (EZRA) | United States | $0.003B | |
| CORVEL CORP (CRVL) | United States | $3.727B | 27.41 |
| RYAN SPECIALTY HOLDINGS, INC. (RYAN) | United States | $4.038B | 67.32 |
| Equitable Holdings, Inc. (EQH) | United States | $14.367B | -12.94 |
| BROWN & BROWN, INC. (BRO) | United States | $20.190B | 17.57 |
| WILLIS TOWERS WATSON PLC (WTW) | $27.268B | 15.77 |